|Day Low/High||110.65 / 111.60|
|52 Wk Low/High||81.66 / 111.73|
U.S. stock futures turn higher Thursday after the Fed commits to further monetary tightening in 2017. Investors also are anticipating the meeting between Donald Trump and Chinese leader Xi Jinping.
Intel added executives from Medtronic and Boeing to its board of directors.
The tie-up between Big Blue and the cloud CRM software leader highlights IBM's unique AI position and strengths.
When it comes to AI solutions meant for specific industries, IBM has a lot of expertise and the ability to cast a broad net.
This patient-monitoring device-maker has plenty of room for growth.
In one scenario, we crack these levels and then come back and retest on the pullback.
We'll sell our remaining shares in Panera and Costco to protect profits and move on.
Four women serve on the boards of four S&P 500 companies at the same time.
More than a dozen people sit on the four boards for components of the S&P 500, of which four are women.
The company discusses potential share repurchases and its acquisition strategy.
With Macy's, Walmart and other retailers reporting this week, steel yourself for the bad news.
The continuous glucose monitor maker is an excellent growth opportunity.
The most ethnically and gender diverse boards may surprise you.
While breadth has faltered, it has not weakened.
The Treasury Department's move to ease sanctions on Russian intelligence agency FSB was good news for Russia ETFs -- and U.S. exporters.
Here's how to use charts to trade five stocks, including Dow Chemical and Honeywell.
Some of Wall Street's biggest stocks are teetering on the edge of breakout territory this week. Here are five of them.
Jim Cramer highlights bank, health-care companies reporting next week and what to watch.
Dividend growers Texas Instruments, Accenture and Medtronic are superior to companies that simply sport high dividend yields, says one portfolio manager.
An attempt to repeal the Affordable Care Act and the brewing policy war between President-elect Donald Trump and the Democrats won't slow these three health sector juggernauts.
Sirius, Medtronic and Carlyle could be money makers in 2017, says Jim Cramer.
Jim Cramer outlines what he thinks this market needs to keep the Trump rally rolling in 2017.
Here are Tuesday's top research calls, including downgrades for Medtronic, Nokia and Paccar, and an upgrade for Verizon.
While most investors fixate on Dow 20,000, breakouts are already happening in the individual stocks.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.